Menu

Calamine

Also known as: Calamine lotion, Calamine topical suspension

A topical skin protectant for defined uses; drying a weeping poison-plant rash is not the same as diagnosing or curing every itchy rash.

Gouache still life of an amber bottle and dusty-pink lotion
Editorial illustration

Calamine is a topical skin-protectant ingredient, often supplied in a pink lotion or suspension. U.S. labeling includes drying the weeping of poison ivy, oak or sumac, and dermatology guidance includes it for mild itch relief. That role does not establish an infection treatment or a universal remedy for an unidentified rash.1, 2, 4

  • M016 lists calamine at 1–25% under its full topical skin-protectant conditions.1
  • The illustrative label lists calamine 8% and zinc oxide 8% as separate actives.2
  • Blister fluid does not spread poison-plant rash; residual plant oil can cause another exposure.3, 5

What is Calamine?

A calamine lotion can contain an additional active: the specific Drug Facts example cited here lists calamine and zinc oxide separately. Read the actual label rather than assigning every formula the same contents or claims. Poison-plant contact dermatitis begins with urushiol exposure; covering the rash does not remove oil left on clothing or tools.2, 5

Where it comes from

Natural sources

  • The assessed medicinal labels do not define a naturally harvested remedy.

How it's made

A specified medicinal material formulated into topical products; the word calamine is not a formula for every bottle's active and inactive ingredients.

What it does in products

  • Active ingredient in topical skin-protectant lotions or suspensions

Benefits

A defined drying and comfort role

limited evidence

The regulatory claim concerns poison-plant weeping, while clinical guidance includes relief of mild itching.1, 3, 4

M016, FDA consumer guidance and AAD advice identify this use. They do not quantify faster rash resolution or establish superiority to corticosteroids. This review is guidance- and labeling-based, not a comparative calamine trial analysis.

Evidence scope and limitations

Calamine's poison-plant protectant role, professional patient guidance and one example of combination labeling; not every rash, product or permitted use.

  • Guidance identifies a role but does not supply a calamine-specific effect size or comparative healing-time estimate.
  • One label cannot establish that every lotion has the same actives, vehicle or warnings.
  • Drying weeping and treating an infection or underlying inflammatory disorder are different endpoints.
  • Severe or unidentified rash is outside the mild localized home-care context.

Evidence last checked: 2026-10-12

Side effects & safety

Worsening irritation or a poor match for the rash (varies)The cited label requires stopping and obtaining advice if the condition worsens. It does not provide an adverse-reaction frequency or clear every formula's inactive ingredients.

Safety considerations

  • Do not assume another anti-itch active has the same restrictions as a plain protectant. AAD warns that topical antihistamines can worsen poison-plant rash; inspect a combination's ingredients separately.
  • Not for: External use only; avoid eyes. Swallowing requires medical or poison-control advice.
  • Not for: The label calls for assessment if symptoms last over seven days or recur quickly.
  • Not for: Breathing or swallowing difficulty, major facial swelling or a widespread severe reaction needs urgent medical evaluation, not repeated lotion application.
2, 4, 3

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

In skincare studies and products

M016's 1–25% range is a regulatory condition, not an optimal DIY concentration. The cited combination label has two 8% actives and directs shaking before use. A suspension's mixing instructions and the actual label matter; do not infer an oral dose or a universal application schedule.

1, 2

Regulatory status

  • M016 addresses the conditions and labeling for OTC topical skin protectants. Calamine's specified poison-plant drying claim is not blanket permission for disease-treatment marketing, and a DailyMed listing is not a comparative efficacy endorsement or product recommendation.
1, 2

Treat the exposure as well as the visible rash

Oil remaining on clothing, equipment or pets can cause another contact. The apparent spread is not proof that blister fluid is infectious. A lotion addresses a symptom context; it cannot substitute for recognizing and removing residual urushiol exposure.

Our reading: identify the rash before choosing the comforting pink bottle. Mild, localized poison-plant dermatitis and a rapidly worsening, infected or extensive rash require different decisions. Do not scratch or intentionally open blisters just to make a drying product seem more relevant.

3, 5, 4

Frequently asked questions

Is every calamine lotion the same formula?

No. The label example includes separate calamine and zinc oxide actives. Other added ingredients need their own warnings; a color or familiar name is not a complete ingredient list.2, 4

Does drying a rash prove the underlying cause has been treated?

No. Guidance limits home care to a mild, known poison-plant rash. Uncertain cause, infection signs or a severe reaction warrants assessment instead of assuming that symptom relief establishes a diagnosis.4, 5

The bottom line

Match the protectant to its actual label and a known, limited symptom context; the appearance of a rash is not enough to diagnose it.

References

  1. OTC Monograph M016: Skin Protectant Drug Products for OTC Human Use. U.S. Food and Drug Administration (2021) · government guidance · M016; OTC000005; posted September 24, 2021; sections M016.10(c) and M016.50
  2. Calamine, zinc oxide lotion: Drug Facts. DailyMed / U.S. National Library of Medicine (2026) · ingredient monograph · SPL set ID 4a79259e-64ac-d187-e063-6294a90a78db; updated June 15, 2026; illustrative labeling, not a product recommendation
  3. Outsmarting Poison Ivy and Other Poisonous Plants. U.S. Food and Drug Administration · government guidance · Undated consumer guidance; checked October 12, 2026
  4. Poison ivy, oak, and sumac: How to treat the rash. American Academy of Dermatology (2026) · clinical guideline · Professional society patient guidance; updated June 1, 2026; not a comparative trial
  5. Poison ivy - oak - sumac rash. MedlinePlus Medical Encyclopedia (2025) · government guidance · Reviewed July 3, 2025

Revision history

  1. Initial AI-assisted source checks and claim-level citation mapping under the site-authorized publishing workflow. No separate human or independent medical review is claimed.